GlassScriptPhysician profile
Bruce J Rochefort
NPI 1407806581
$2,889.98
in general payments reported to CMS, 2019-2025
25 companies · $182 in 2025
The $182 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $288 · 2020: $121 · 2021: $348 · 2022: $816 · 2023: $546 · 2024: $590 · 2025: $182.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,224 · Education: $94.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,223.59 |
| Education | $94.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $554.02 | 2019-2024 | Orilissa |
| Sumitomo Pharma America, INC. | $368.07 | 2023-2025 | Myfembree |
| Myovant Sciences INC. | $299.31 | 2021-2022 | |
| Hologic Sales and Service, LLC | $272.87 | 2019-2025 | Aptima, Thinprep 2000 Processor, Coolseal Generator |
| Organon LLC | $254.54 | 2022-2024 | |
| Coopersurgical, INC. | $204.60 | 2019-2022 | |
| Astellas Pharma US INC | $204.54 | 2023-2025 | Veozah |
| Mayne Pharma Commercial LLC | $121.49 | 2021-2024 | |
| Agile Therapeutics, INC. | $112.52 | 2021-2022 | |
| Avion Pharmaceuticals | $84.92 | 2019-2022 | |
| Sage Therapeutics, LLC | $54.40 | 2024-2025 | Zurzuvae |
| Exact Sciences Corporation | $48.67 | 2023-2025 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $48.43 | 2023 | |
| Pfizer INC. | $46.26 | 2023 | |
| Evofem Biosciences, INC. | $33.94 | 2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $31.82 | 2020-2022 | |
| Gynesonics, INC. | $24.81 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Smith+Nephew, INC. | $23.64 | 2023 | Pico 7 |
| Scynexis, INC. | $19.54 | 2022 | |
| Kci USA, INC. | $16.76 | 2023 | V.A.C.Ulta, V.A.C. Veraflo, Prevena |
| Mylan Pharmaceuticals INC. | $14.71 | 2021 | |
| Daiichi Sankyo INC. | $13.94 | 2021 | |
| Meditrina | $13.46 | 2024 | |
| Allergan, INC. | $11.46 | 2020 | |
| Duchesnay USA Incorporated | $11.26 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bruce Rochefort listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.